Following a review of available clinical data, Immunovant has announced plans to resume clinical testing of the investigational medication…
Articles by Marisa Wexler, MS
People with myasthenia gravis (MG) who have difficulty swallowing are more likely to have poor clinical outcomes, according to…
Editor’s note: The Myasthenia Gravis News team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
When used over long periods of time, Soliris (eculizumab) does not increase the risk of infections in people with…
The U.S. Food and Drug Administration (FDA) is now reviewing an application from Argenx that seeks approval of …
In a $3.05 billion deal, Horizon Therapeutics will acquire Viela Bio, the developer of inebilizumab, a potential treatment for autoimmune…
After unanimous votes by the boards of directors of both companies, AstraZeneca has announced it will acquire Alexion…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
The first published case of a person developing ocular myasthenia gravis (MG) secondary to COVID-19 was described in…